Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical compositions comprising DENND1A variant 2 and methods of use thereof

Pharmaceutical compositions comprising DENND1A variant 2 and methods of use thereof

US Patent 9676844 · Granted Jun 13, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods relating to DENND1A variant 2 and polycystic ovary synd2020
Compositions and methods relating to DENND1A variant 2 and polycystic ovary synd2020
Method for diagnosis of polycystic ovary syndrome (PCOS) by measuring levels of 2020
Method for diagnosis of polycystic ovary syndrome (PCOS) by measuring levels of 2020
Method for diagnosis of polycystic ovary syndrome (PCOS) by measuring levels of 2020
Antibodies that recognize a DENN/MADD-domain-containing 1A variant 2 (DENND1A va2019
Antibodies that recognize a DENN/MADD-domain-containing 1A variant 2 (DENND1A va2019
Antibodies that recognize a DENN/MADD-domain-containing 1A variant 2 (DENND1A va2019
Compositions and methods for targeting of the surfactant protein A receptor2018
Methods relating to DENND1A Variant 2 and polycystic ovary syndrome2018
Methods relating to DENND1A Variant 2 and polycystic ovary syndrome2018
Identification and characterization of a specific CCK-C receptor antibody for hu2014